The clinical effectiveness and cost-effectiveness of the PROGENSA&#174; prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation

Nicholson?A; Mahon?J; Boland?A; Beale?S; Dwan?K; Fleeman?N; Hockenhull?J; Dundar?Y

首页> 外文期刊>Health technology assessment: HTA >The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation

【24h】

The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation

机译：PROGENSA＆＃174;的临床疗效和成本效益;前列腺癌抗原3检测和前列腺健康指数在前列腺癌诊断中的作用：系统评价和经济评价

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Health technology assessment: HTA》 |2015年第87期|共页
作者
Nicholson?A; Mahon?J; Boland?A; Beale?S; Dwan?K; Fleeman?N; Hockenhull?J; Dundar?Y;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类放射卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Protocol for a systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer [J] . Health technology assessment: HTA . 2012,第41期

机译：对腹腔镜手术和机器人手术切除局部前列腺癌男性患者的相对临床收益和成本效益进行系统回顾和经济建模的协议
2. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer [J] . Health technology assessment: HTA . 2012,第41期

机译：腹腔镜手术和机器人手术切除局部前列腺癌男性相对临床利益和成本效益的系统评价和经济模型
3. Scrutiny of Prostate Cancer Antigen 3 Effectiveness as an Assist of Prostatic Specific Antigen in Screening and Early Diagnosis of Prostate Cancer: A Review [J] . Farid Azizi Jalilian, Mohammad Soleimani, Mohsen Alemi, Nephro-Urology Monthly . 2017,第6期

机译：审查前列腺癌抗原3作为前列腺特异性抗原在前列腺癌的筛查和早期诊断中的辅助手段：综述
4. Accurate Diagnosis for Prostate Cancer Measuring the Ratio between Two Types of Prostate Specific Antigens by LDI-TOF MS [C] . Minyoung Yoo, Woon-Seok Yeo ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：准确诊断前列腺癌测量通过LDI-TOF MS测量两种前列腺特异性抗原的比率
5. Mapping Expanded Prostate Cancer Index Composite (EPIC) Questionnaire to EuroQoL-5D (EQ-5D) Utility Weights to Inform Economic Evaluations for Prostate Cancer [D] . Khairnar, Rahul. 2020

机译：将扩大的前列腺癌指数复合（EPIC）问卷调查问卷到EUROQOL-5D（EQ-5D）实用权重，以便为前列腺癌提供经济评估
6. The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation. [O] . Amanda Nicholson, James Mahon, Angela Boland, -1

机译：PROGENSA®前列腺癌抗原3测定法和前列腺健康指数在前列腺癌诊断中的临床有效性和成本效益：系统评价和经济评估。
7. The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation [O] . Nicholson, A, Mahon, J, Boland, A, 2015

机译：PROGENSA®前列腺癌抗原3测定法和前列腺健康指数在前列腺癌诊断中的临床有效性和成本效益：系统评价和经济评估
8. Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review. Comparative Effectiveness Review Number 146. [R] . 2014

机译：临床局限性前列腺癌的治疗：2008年系统评价的更新。比较效力审查编号146。

The clinical effectiveness and cost-effectiveness of the PROGENSA&#174; prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation

著录项

相似文献

相关主题

期刊订阅

The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation